NTRK gene fusions as novel targets of cancer therapy across multiple tumour types

Por Amatu, Alessio, Sartore-Bianchi, Andrea, Siena, Salvatore
Publicado no ESMO Open (2016)

Skin toxicity and quality of life during treatment with panitumumab for RAS wild-type metastatic colorectal carcinoma: results from three randomised clinical trials

Por Koukakis, Reija, Gatta, Francesca, Hechmati, Guy, Siena, Salvatore
Publicado no Qual Life Res (2016)

Aspirin for colorectal cancer with PIK3CA mutations: the rising of the oldest targeted therapy?

Por Amatu, Alessio, Bencardino, Katia, Sartore-Bianchi, Andrea, Siena, Salvatore
Publicado em 2013

Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor–Targeted Therapy in Metastatic Colorectal Cancer

Por Siena, Salvatore, Sartore-Bianchi, Andrea, Di Nicolantonio, Federica, Balfour, Julia, Bardelli, Alberto
Publicado em 2009

An analysis of the treatment effect of panitumumab on overall survival from a phase 3, randomized, controlled, multicenter trial (20020408) in patients with chemotherapy refractory...

Por Poulin-Costello, Melanie, Azoulay, Laurent, Van Cutsem, Eric, Peeters, Marc, Siena, Salvatore, Wolf, Michael
Publicado em 2013

Immunomodulatory Effects in a Phase II Study of Lenalidomide Combined with Cetuximab in Refractory KRAS-Mutant Metastatic Colorectal Cancer Patients

Por Gandhi, Anita K., Shi, Tao, Li, Mingyu, Jungnelius, Ulf, Romano, Alfredo, Tabernero, Josep, Siena, Salvatore, Schafer, Peter H., Chopra, Rajesh
Publicado em 2013

Clonal evolution and KRAS-MET coamplification during secondary resistance to EGFR-targeted therapy in metastatic colorectal cancer

Por Sartore-Bianchi, Andrea, Valtorta, Emanuele, Amatu, Alessio, Veronese, Silvio, Lauricella, Calogero, Bonazzina, Erica, Siravegna, Giulia, Truini, Mauro, Bardelli, Alberto, Siena, Salvatore
Publicado no ESMO Open (2016)

KRAS Mutations Testing in Colorectal Carcinoma Patients in Italy: From Guidelines to External Quality Assessment

Por Normanno, Nicola, Pinto, Carmine, Castiglione, Francesca, Bardelli, Alberto, Gambacorta, Marcello, Botti, Gerardo, Nappi, Oscar, Siena, Salvatore, Ciardiello, Fortunato, Taddei, GianLuigi, Marchetti, Antonio
Publicado em 2011

Quality of life during first-line FOLFOX4±panitumumab in RAS wild-type metastatic colorectal carcinoma: results from a randomised controlled trial

Por Siena, Salvatore, Tabernero, Josep, Bodoky, Gyorgy, Cunningham, David, Rivera, Fernando, Ruff, Paul, Canon, Jean Luc, Koukakis, Reija, Demonty, Gaston, Hechmati, Guy, Douillard, Jean-Yves
Publicado no ESMO Open (2016)

Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study

Por Gori, Stefania, Clavarezza, Matteo, Siena, Salvatore, Foglietta, Jennifer, Tarenzi, Emiliana, Giordano, Monica, Molino, Annamaria, Graiff, Claudio, Fusco, Vittorio, Alabiso, Oscar, Baldini, Editta, Gamucci, Teresa, Altavilla, Giuseppe, Dondi, Davide, Venturini, Marco
Publicado em 2012

Multi-Determinants Analysis of Molecular Alterations for Predicting Clinical Benefit to EGFR-Targeted Monoclonal Antibodies in Colorectal Cancer

Por Sartore-Bianchi, Andrea, Di Nicolantonio, Federica, Nichelatti, Michele, Molinari, Francesca, De Dosso, Sara, Saletti, Piercarlo, Martini, Miriam, Cipani, Tiziana, Marrapese, Giovanna, Mazzucchelli, Luca, Lamba, Simona, Veronese, Silvio, Frattini, Milo, Bardelli, Alberto, Siena, Salvatore
Publicado em 2009

Phase II Open-Label Study to Assess Efficacy and Safety of Lenalidomide in Combination with Cetuximab in KRAS-Mutant Metastatic Colorectal Cancer

Por Siena, Salvatore, Van Cutsem, Eric, Li, Mingyu, Jungnelius, Ulf, Romano, Alfredo, Beck, Robert, Bencardino, Katia, Elez, Maria Elena, Prenen, Hans, Sanchis, Mireia, Sartore-Bianchi, Andrea, Tejpar, Sabine, Gandhi, Anita, Shi, Tao, Tabernero, Josep
Publicado em 2013

Epigenetic Inactivation of the BRCA1 Interactor SRBC and Resistance to Oxaliplatin in Colorectal Cancer

Por Moutinho, Catia, Martinez-Cardús, Anna, Santos, Cristina, Navarro-Pérez, Valentin, Martínez-Balibrea, Eva, Musulen, Eva, Carmona, F. Javier, Sartore-Bianchi, Andrea, Cassingena, Andrea, Siena, Salvatore, Elez, Elena, Tabernero, Josep, Salazar, Ramon, Abad, Albert, Esteller, Manel
Publicado em 2013

Standardisation of EGFR FISH in colorectal cancer: results of an international interlaboratory reproducibility ring study

Por Sartore-Bianchi, Andrea, Fieuws, Steffen, Veronese, Silvio, Moroni, Mauro, Personeni, Nicola, Frattini, Milo, Torri, Valter, Cappuzzo, Federico, Borght, Sara Vander, Martin, Vittoria, Skokan, Margaret, Santoro, Armando, Gambacorta, Marcello, Tejpar, Sabine, Varella-Garcia, Marileila, Siena, Salvatore
Publicado no J Clin Pathol (2011)

Sorafenib in locally advanced or metastatic, radioactive iodine-refractory, differentiated thyroid cancer: a randomized, double-blind, phase 3 trial

Por Brose, Marcia S, Nutting, Christopher M, Jarzab, Barbara, Elisei, Rossella, Siena, Salvatore, Bastholt, Lars, de la Fouchardiere, Christelle, Pacini, Furio, Paschke, Ralf, KeeShong, Young, Sherman, Steven I, Smit, Johannes WA, Chung, John, Kappeler, Christian, Pena, Carol, Molnár, István, Schlumberger, Martin J
Publicado no Lancet (2014)

A clinical pharmacogenetic characterization of DPD polymorphisms for pre-treatment screening of patients candidates to fluoropyrimidine therapy

Por Del Re, Marzia, Loupakis, Fotios, Barbara, Cecilia, Lombardo, Laura, Latiano, Tiziana, Zafarana, Elena, Cordio, Stefano, Toffolatti, Luisa, Ricasoli, Miriam, Giuffrida, Dario, Vanoli, Jennifer, Di Donato, Samantha, Grifalchi, Federico, Rinaldi, Antonio, Butera, Alfredo, Maiello, Evaristo, Siena, Salvatore, Brandes, Alba, Falcone, Alfredo, Cappuzzo, Federico, Danesi, Romano
Publicado em 2014

Novel CAD-ALK gene rearrangement is drugable by entrectinib in colorectal cancer

Por Amatu, Alessio, Somaschini, Alessio, Cerea, Giulio, Bosotti, Roberta, Valtorta, Emanuele, Buonandi, Pasquale, Marrapese, Giovanna, Veronese, Silvio, Luo, David, Hornby, Zachary, Multani, Pratik, Murphy, Danielle, Shoemaker, Robert, Lauricella, Calogero, Giannetta, Laura, Maiolani, Martina, Vanzulli, Angelo, Ardini, Elena, Galvani, Arturo, Isacchi, Antonella, Sartore-Bianchi, Andrea, Siena, Salvatore
Publicado no Br J Cancer (2015)

Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer

Por Van Emburgh, Beth O., Arena, Sabrina, Siravegna, Giulia, Lazzari, Luca, Crisafulli, Giovanni, Corti, Giorgio, Mussolin, Benedetta, Baldi, Federica, Buscarino, Michela, Bartolini, Alice, Valtorta, Emanuele, Vidal, Joana, Bellosillo, Beatriz, Germano, Giovanni, Pietrantonio, Filippo, Ponzetti, Agostino, Albanell, Joan, Siena, Salvatore, Sartore-Bianchi, Andrea, Di Nicolantonio, Federica, Montagut, Clara, Bardelli, Alberto
Publicado no Nat Commun (2016)

Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer

Por Sartore-Bianchi, Andrea, Ardini, Elena, Bosotti, Roberta, Amatu, Alessio, Valtorta, Emanuele, Somaschini, Alessio, Raddrizzani, Laura, Palmeri, Laura, Banfi, Patrizia, Bonazzina, Erica, Misale, Sandra, Marrapese, Giovanna, Leone, Antonella, Alzani, Rachele, Luo, David, Hornby, Zachary, Lim, Jonathan, Veronese, Silvio, Vanzulli, Angelo, Bardelli, Alberto, Martignoni, Marcella, Davite, Cristina, Galvani, Arturo, Isacchi, Antonella, Siena, Salvatore
Publicado no J Natl Cancer Inst (2015)

Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients

Por Vincenzi, Bruno, Cremolini, Chiara, Sartore-Bianchi, Andrea, Russo, Antonio, Mannavola, Francesco, Perrone, Giuseppe, Pantano, Francesco, Loupakis, Fotios, Rossini, Daniele, Ongaro, Elena, Bonazzina, Erica, Dell'Aquila, Emanuela, Imperatori, Marco, Zoccoli, Alice, Bronte, Giuseppe, De Maglio, Giovanna, Fontanini, Gabriella, Natoli, Clara, Falcone, Alfredo, Santini, Daniele, Onetti-Muda, Andrea, Siena, Salvatore, Tonini, Giuseppe, Aprile, Giuseppe
Publicado no Oncotarget (2015)